Q2 news in 6 daysWell better late than never on posting the release date for Q2.
I expect a Q2 loss of $25 million, a positive spin on raising 50 million
net cash and some steady as you go comfort speak, but no firm news
on the FDA. We get a share pop on surprise positive FDA news and a price
drop on perceived negative FDA news. We now trade in the moment, not
the future land of 2022 approvals. Good day for JP Morgan.